Poolbeg Pharma PLC (POLB)

Currency in GBP
4.30
-0.15(-3.37%)
Closed·
POLB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.304.70
52 wk Range
2.405.20
Key Statistics
Bid/Ask
4.20 / 4.90
Prev. Close
4.3
Open
4.5
Day's Range
4.3-4.7
52 wk Range
2.4-5.2
Volume
521.85K
Average Volume (3m)
973.22K
1-Year Change
26.4706%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
POLB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
19.00
Upside
+341.86%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Poolbeg Pharma PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom. The company develops POLB 001, which is completed phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome. It also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; and AI program, a novel drug discovery therapies for the treatment of influenza and respiratory syncytial viruses. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Compare POLB to Peers and Sector

Metrics to compare
POLB
Peers
Sector
Relationship
P/E Ratio
−5.3x−1.2x−0.5x
PEG Ratio
0.190.020.00
Price/Book
2.5x1.4x2.6x
Price / LTM Sales
-1.8x3.2x
Upside (Analyst Target)
327.0%98.1%48.8%
Fair Value Upside
Unlock27.6%7.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 19.00
(+341.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
31-03-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

POLB Income Statement

FAQ

What Is the Poolbeg Pharma (POLB) Share Price Today?

The Poolbeg Pharma share price today is 4.30.

What is the current Poolbeg Pharma (POLB) share price and day range?

As of 29-04-2026, the Poolbeg Pharma share price is 4.30, with a previous close of 4.30. The share price has ranged from 4.30 to 4.70 today, while the 52-week range spans from 2.40 to 5.20.

What Is the Poolbeg Pharma Market Cap?

As of today, Poolbeg Pharma market cap is 30.32M.

What Is the Poolbeg Pharma (POLB) Share Price Target?

The average 12-month share price target for Poolbeg Pharma is 19.00, with a high estimate of 19 and a low estimate of 19. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +341.86% Upside potential.

What Is Poolbeg Pharma's Earnings Per Share (TTM)?

The Poolbeg Pharma EPS (TTM) is -0.01.

When Is the Next Poolbeg Pharma Earnings Date?

Poolbeg Pharma will release its next earnings report on 31-03-2026.

From a Technical Analysis Perspective, Is POLB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

What Stock Exchange Does Poolbeg Pharma Trade On?

Poolbeg Pharma is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Poolbeg Pharma?

The stock symbol for Poolbeg Pharma is "POLB."

How Many Times Has Poolbeg Pharma Stock Split?

Poolbeg Pharma has split 0 times.

How Many Employees Does Poolbeg Pharma Have?

Poolbeg Pharma has 16 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.